| Careen Shearin Foster, MD | |
|
1321 Colby Ave, Everett, WA 98201 | |
| (425) 261-2000 | |
| Not Available |
| Full Name | Careen Shearin Foster |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 1321 Colby Ave, Everett, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932183803 | NPI | - | NPPES |
| 2031727 | Medicaid | WA | |
| 186064503 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | M6034 (Texas) | Secondary |
| 208600000X | Surgery | MD60385717 (Washington) | Primary |
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Steroids should not be used to treat smell loss caused by Covid-19 according to an international group of smell experts, including Prof Carl Philpott from the University of East Anglia.
Senomyx, Inc., a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today provided a corporate update and reported financial results for the first quarter ended March 31, 2011.
UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy.
News coverage focuses on some of the sticky issues in health reform, including immigrants' coverage, long term care for the disabled, CHIP and insurance discounts for healthy habits.
› Verified 7 days ago
| Entity Name | The Everett Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
Steroids should not be used to treat smell loss caused by Covid-19 according to an international group of smell experts, including Prof Carl Philpott from the University of East Anglia.
Senomyx, Inc., a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today provided a corporate update and reported financial results for the first quarter ended March 31, 2011.
UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy.
News coverage focuses on some of the sticky issues in health reform, including immigrants' coverage, long term care for the disabled, CHIP and insurance discounts for healthy habits.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Careen Shearin Foster, MD Po Box 3360, Portland, OR 97208-3360 Ph: (866) 747-2455 | Careen Shearin Foster, MD 1321 Colby Ave, Everett, WA 98201 Ph: (425) 261-2000 |
News Archive
Steroids should not be used to treat smell loss caused by Covid-19 according to an international group of smell experts, including Prof Carl Philpott from the University of East Anglia.
Senomyx, Inc., a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today provided a corporate update and reported financial results for the first quarter ended March 31, 2011.
UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy.
News coverage focuses on some of the sticky issues in health reform, including immigrants' coverage, long term care for the disabled, CHIP and insurance discounts for healthy habits.
› Verified 7 days ago
John L Goodman, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1330 Rockefeller Ave Ste 120, Everett, WA 98201 Phone: 425-339-5422 | |
Elizabeth Neuger, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1330 Rockefeller Ave, Everett, WA 98201 Phone: 425-339-5442 | |
Dr. Perry A Soriano, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1330 Rockefeller Ave, Everett, WA 98201 Phone: 425-339-5442 Fax: 425-339-1363 | |
David F Pratt, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 4005 Colby Ave, Everett, WA 98201 Phone: 425-258-3446 Fax: 425-252-7321 | |
Katherine Ione Moreno, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3216 Norton Ave, Ste 202, Everett, WA 98201 Phone: 425-297-5330 | |
Dr. Kenny P Koo, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1330 Rockefeller Ave, #120, Everett, WA 98201 Phone: 425-339-5442 | |
James K Brevig, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1330 Rockefeller Ave, Suite 400, Everett, WA 98201 Phone: 425-261-4950 Fax: 425-261-4951 |